Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy
Clinical trial NCT03982121 · WITHDRAWN
Trial details
- NCT number
- NCT03982121
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2020-02-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.